• Explore /
  • Poster
  • / Efficacy of immune checkpoint inhibitors in patients with HIV-associated unresectable HCC (uHCC): Propensity-score matched analyses from two international consortia.

Efficacy of immune checkpoint inhibitors in patients with HIV-associated unresectable HCC (uHCC): Propensity-score matched analyses from two international consortia.

Abstract Poster

Authors

null

Claudia A.M. Fulgenzi

Department of Surgery and Cancer, Imperial College, Hammersmith Hospital, London, United Kingdom

Claudia A.M. Fulgenzi , Talal El Zarif , Amin Nassar , Elio Adib , Joaquim Bellmunt , Thomas Urban Marron , Michael Lorentsen , Rana R. McKay , Javier Baena , Celina Ang , Lorenza Rimassa , Masatoshi Kudo , Alessandro Parisi , Anwaar Saeed , Pei-Chang Lee , Neehar Parikh , Matthias Pinter , Alessio Cortellini , Abdul Rafeh Naqash , David James Pinato

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 442)

DOI

10.1200/JCO.2024.42.3_suppl.442

Abstract #

442

Poster Bd #

A7

Abstract Disclosures

Similar Posters

First Author: Keito Suzuki

First Author: Leijuan Gan

First Author: Ghassan K. Abou-Alfa

First Author: Manabu Muto